Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review.

Authors:
Park J; Lee H; Kim Y; Norton C; Woodward S and 1 more

Journal:
Int Neurourol J

Publication Year: 2023

DOI:
10.5213/inj.2346014.007

PMCID:
PMC10073005

PMID:
37015722

Journal Information

Full Title: Int Neurourol J

Abbreviation: Int Neurourol J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest: No potential conflict of interest relevant to this article was reported."

Evidence found in paper:

"Grant/Fund Support: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2019R1F1A1062769, No. 2020R1A6A1A03041989, No. 2022R1A2C1092084). This research was supported by the Brain Korea 21 FOUR Project funded by the NRF of Korea, Yonsei University College of Nursing. This research was supported by a 2022 International Joint Research Grant from Mo-Im Kim Nursing Research Institute, Yonsei University College of Nursing (Project No. 6–2022-0152). AUTHOR CONTRIBUTION STATEMENT: • Conceptualization: JP, SL: • Data curation: JP, HL, YK, SL: • Formal analysis: JP, HL, YK, SL: • Funding acquisition: JP: • Methodology: JP, HL, YK, CN, SW, SL: • Project administration: JP, HL, YK, SL: • Visualization: JP, SL: • Writing - original draft: JP, CN, SW, SL: • Writing - review & editing: JP, HL, YK, CN, SW, SL"

Evidence found in paper:

"A systematic review of randomized controlled trial (RCT) studies and quasi-experimental studies (QESs) which evaluated the effectiveness of fluid or caffeine intake modifications on OAB symptoms in adults. A QES is an experimental study without randomization or a control group []. The study protocol was prospectively registered on PROSPERO (No. CRD42022293799)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025